TransS1, a medical device maker of minimally invasive surgical products to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, has named Ken Reali as its new president and COO, according to a TransS1 news release.
Mr. Reali has over 20 years of general management, sales and marketing experience with leading medical device and orthopedic companies. He joins TranS1 from Smith & Nephew where he was most recently senior vice president and general manager of the biologics and spine business. Prior to Smith & Nephew, Mr. Reali held positions with Stryker and Biomet.
Learn more about TransS1.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.